Ignite Creation Date:
2025-12-24 @ 5:46 PM
Ignite Modification Date:
2026-01-01 @ 5:12 AM
Study NCT ID:
NCT00903968
Status:
COMPLETED
Last Update Posted:
2020-06-02
First Post:
2009-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-18
First Submit QC Date:
None
Study First Post Date:
2009-05-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-31
Results First Submit QC Date:
None
Results First Post Date:
2017-09-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-19
Last Update Post Date:
2020-06-02
Last Update Post Date Type:
ACTUAL